In this week's EuroBiotech Report, Iterum raises $65 million for phase 3, a J&J incubator gets a dedicated VC fund, Merck KGaA accepts an Ablynx asset…

Harpoon Therapeutics has raised $45 million in its second funding round as it looks to get its I-O candidates into the clinic as well as boosting its pipeline…

In our EuroBiotech roundup this week, investor spurns a £500 million offer, Actelion tees up a $230 million J&J decision and more.

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.

Merck has today penned a new licensing deal with Tokyo’s Teijin Pharma for its investigational tau-targeting antibody candidate in Alzheimer’s.

The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong.

OrphoMed gained a $39 million early funding boost from a Japanese big pharma and a host of VCs as it looks to push on with work on its leading med for forms of…

The U.K. has been closing the gap on life sciences sectors in Boston and San Francisco, but uncertainty caused by Brexit may undermine those efforts, said the…

Biotech